
Figure 1. Buserelin-induced concentration-dependent stimulation of intracellular calcium mobilization in CHO-K1/GNRHR/Gα15 cells. The cells were loaded with Calcium-4 (Cat. No. R8142; Molecular Devices) prior to stimulation with GNRHR agonist, buserelin. The intracellular calcium change was measured by FLIPRTETRA. The relative fluorescent units (RFU) were recorded and normalized to plot against the log of the cumulative doses of buserelin (mean ± SEM, n = 3). The EC50 of buserelin on CHO-K1/GNRHR/Gα15 cells was 9.83 nM.
Notes:
EC50 value is calculated with four parameter logistic equation:
Y=Bottom + (Top-Bottom) / (1+10^((LogEC50-X)*Hill Slope))
X is the logarithm of concentration. Y is the response.
Y is ∆RFU and starts at Bottom and goes to Top along a sigmoid curve.

Figure 2. Dose dependent stimulation of intracellular IP-One accumulation upon treatment with buserelin in CHO-K1/GNRHR/Gα15 cells. d2 acceptor fluorophore-labeled IP-One (Cat. No. 62IPAPEB; Revvity) and intracellular IP-One in CHO-K1/GNRHR/Gα15 cells competitively bind with Europium Cryptate-labeled anti-IP-One antibody. The FRET signal decreases as the intracellular IP-One concentration rises and was measured by plate reader (Pherastar, BMG). The EC50 of buserelin on CHO-K1/GNRHR/Gα15 cells was 81.97 nM.
CHO-K1/GNRHR/Gα15 Stable Cell Line
M00426 | |
|
|
¥1,661,121.00 | |
|
|
|
|
Ask us a question |